Similar articles

• The role of pegfilgrastim in mobilization of hematopoietic stem cells.

  Kroschinsky F, Hölig K, Ehninger G. Kroschinsky F, et al. Transfus Apher Sci. 2008 Jun;38(3):237-44. doi: 10.1016/j.transci.2008.04.007. Epub 2008 May 19. Transfus Apher Sci. 2008. PMID: 18490197 Review.
• Differences between graft product and donor side effects following bone marrow or stem cell donation.

  Favre G, Beksaç M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley J, Szer J, Bradstock K, Buzyn A, Matcham J, Gratwohl A, Schmitz N; European Group for Blood and Marrow Transplantation (EBMT). Favre G, et al. Bone Marrow Transplant. 2003 Nov;32(9):873-80. doi: 10.1038/sj.bmt.1704245. Bone Marrow Transplant. 2003. PMID: 14561987 Clinical Trial.
• Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion.

  Nicolini FE, Wattel E, Michallet AS, Bourgeot JP, Tremisi JP, Hequet O, Michallet M. Nicolini FE, et al. Exp Hematol. 2004 Nov;32(11):1033-9. doi: 10.1016/j.exphem.2004.07.021. Exp Hematol. 2004. PMID: 15539080
• Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.

  Anderlini P, Chan FA, Champlin RE, Körbling M, Strom SS. Anderlini P, et al. Bone Marrow Transplant. 2002 Nov;30(10):661-3. doi: 10.1038/sj.bmt.1703693. Bone Marrow Transplant. 2002. PMID: 12420204
• [Recent progress in the field of hematopoietic stem cell transplantation for leukemia].

  Kobayashi T, Akiyama H. Kobayashi T, et al. Gan To Kagaku Ryoho. 2009 Mar;36(3):351-6. Gan To Kagaku Ryoho. 2009. PMID: 19295257 Review. Japanese.